HCM IV Acquisition Corp. is a special purpose acquisition company (SPAC) dedicated to merging with high-growth enterprises, with a primary focus on the technology, healthcare, and consumer sectors. The company is backed by an experienced management team that leverages strong industry relationships to identify and capitalize on innovative market opportunities. Amidst a dynamic SPAC landscape, HCM IV is well-positioned to navigate emerging trends, with a strategic goal of delivering robust returns for its investors through its targeted merger strategy.
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | — |
| Operating Margin | 0.00% |
| Return on Equity | 0.00% |
| Return on Assets | 0.00% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $-0.44 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | 0 |
| Float | $28.75M |
| % Insiders | 0.52% |
| % Institutions | 95.91% |
Volatility is currently contracting
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on HACQU and any ticker you trade — then tracks every position and per-strategy win rate.